StratDeck

Gilead Sciences

GILDHealthcare · Drug Manufacturers - General · US
168.98USDStratDeckSEC EDGARYahoo Finance

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

1D−0.8%1W−0.4%1M+10.4%

Loading chart…

Checks

  • Locked: Price trend
  • Locked: Sales growth against its peers
  • Locked: Profit against similar companies
  • Locked: What analysts expect
  • Locked: Price against what it earns
  • Locked: Last quarter against forecasts

See how Gilead Sciences does on each check. Sign in for two weeks free, with no card. Then StratDeck Pro is £5.99 a month or £60 a year.

Sign in